PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial 3. Februar 2022 3. Februar 2022 Share EmailTwitterFacebookGoogle +PinterestTumblrLinkedinVkontakte